Lawmakers grill consulting company over work with opioid manufacturers and FDA at same time

Healey said McKinsey actively worked to advise drug companies to fight off government regulations for addictive prescription drugs.

“The answer to that is quite simply absolutely,” said Healey. “McKinsey was actively coaching Purdue on how to ban together with other opioid companies to fight against those stricter safety requirements.” “It looked at a time period of the work without examining the nature of the work,” said Bob Sternfels, Global Managing Partner for McKinsey & Company. “It implied incorrect conflict standards and it took large speculative leaps to reach unwarranted findings.”

On Tuesday, lawmakers said the FDA announced changes to its contracts with McKinsey as the investigation is underway.

Why leave their name out of the headlines? Why were they left out of any mention in Dopesick? They’d been helping all along. This is how they operate and who they are- they pump out corp CEOs and politicians in the grandest global good ol’ boy network 1/

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

FDA approves Remdesivir to treat COVID in young childrenThe antiviral drug is given as an injection. It was previously approved for patients 12 years of age and older.
Source: WTVYNews4 - 🏆 590. / 51 Read more »

Coronavirus: FDA approves first COVID-19 treatment for children younger than 12The FDA said Monday it expanded the approval of Veklury to include pediatric patients in certain circumstances.
Source: KIRO7Seattle - 🏆 271. / 63 Read more »

FDA Issues Warning About Large Percentage Of False Positives In Prenatal Screening TestsThe FDA emphasized that certain prenatal screening tests only show the risk of certain genetic abnormalities and should not be interpreted as a diagnostic test.
Source: ScaryMommy - 🏆 116. / 63 Read more »

FDA approves COVID drug for children, China deals with uphill COVID battle, and more COVID newsThe US Food and Drug Administration announced Monday that it has expanded approval of the COVID-19 drug remdesivir to treat patients as young as 28 days old. Here's that and more COVID news.
Source: dothaneagle - 🏆 337. / 59 Read more »

FDA approves first COVID-19 treatment for children under 12 years oldThe FDA gave approval to the use of Veklury (remdesivir) for children 28 days and older who weigh at least 3 kilograms (about 7 pounds).
Source: PennLive - 🏆 463. / 53 Read more »

FDA approves Remdesivir to treat COVID in young childrenThe antiviral drug is given as an injection. It was previously approved for patients 12 years of age and older.
Source: wsfa12news - 🏆 338. / 59 Read more »